Clinical Distribution Characteristics and Identification for Significant Liver Inflammation of Patients in Chronic Hepatitis B with Indeterminate Phase

Figure 3

(a) The severity of liver inflammation grade with different immune states; A: indeterminate phase; B: immune-tolerant phase; C: HBeAg-positive immune active phase; D: inactive phase; E: HBeAg-negative immune active phase. (b) The severity of liver fibrosis stage with different immune states; A: indeterminate phase; B: immune-tolerant phase; C: HBeAg-positive immune active phase; D: inactive phase; E: HBeAg-negative immune active phase.